Cantai Therapeutics operates as a developer of drug candidates.
Cantai Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
Cantai Therapeutics's investors include Agent Capital, 82VS, Tellus BioVentures.
Cantai Therapeutics is headquartered in Philadelphia, United States.
Cantai Therapeutics operates as a developer of drug candidates.
Cantai Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cantai Therapeutics — Funding & Investors." VCBacked, July 15, 2025, https://www.vcbacked.co/company/cantai-therapeutics. Accessed August 17, 2026.
VCBacked. (2025). Cantai Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/cantai-therapeutics
{{cite web |title=Cantai Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cantai-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated